Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 83.97 | (627.10) | (478.36)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 137.78 | (661.73) | (484.14)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 379.32 | (444.80) | (304.73)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
Amgen picks up new heart drug | 28-May-2009 | Chicago Tribune |
Amgen pays $50 million for rights to heart drug | 27-May-2009 | LA Times |
A Tough Quarter for Some Drug Makers | 26-Jan-2007 | New York Times |
Currency | US Dollars |
Share Price | $ 48.55 |
Change Today | $ 0.30 |
% Change | 0.62 % |
52 Week High | $58.62 |
52 Week Low | $29.84 |
Volume | 1,930 |
Shares Issued | 55.37m |
Market Cap | $2,688.37m |
RiskGrade | 332 |
Strong Buy | 3 |
Buy | 12 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 20 |
You are here: research